Novartis to buy Avidity Biosciences for $12bn – Financial Times

Deal for specialist in rare diseases is biggest acquisition under chief executive Vas Narasimhan

#stockmarket #breaking

Leave a Reply

WP Twitter Auto Publish Powered By : XYZScripts.com